Follow The Filings

CDXS Codexis Inc.

Industrials, filed as CODEXIS INC (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

  • 1 Owner
  • Max 1.4%
  • $15M

Who owns this now

Largest portfolio weights among holders, up to 1.4% (James Silverman, Opaleye Management). Not free-float ownership.

  1. James Silverman 1.4%

Who owns CDXS

Sorted by value, long equity only, as of 2026 Q2.

History
James Silverman, Opaleye Management 1.4% Hold 6,785,000 $15M History

1 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by CDXS's executives, directors and 10% owners in the last 12 months, from their Form 4s

All CDXS insider trades
  • None no insider bought on the open market
  • $4.9M sold by 2 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Opaleye Management Inc. 10% owner
    Sale
    $878K 514,341 shares at $1.71 74% of stake
    Traded Nov 26, 2025–Dec 1, 2025 Filed Dec 15, 2025
    ↗
  2. Opaleye Management Inc. 10% owner
    Sale
    $1.9M 1,063,211 shares at $1.76 83% of stake
    Traded Nov 7–11 Filed Dec 15, 2025
    ↗
  3. Dennis P Wolf Director
    Sale
    $14K 8,952 shares at $1.56 6.1% of stake
    Traded Nov 21, 2025 Filed Nov 25, 2025
    ↗
  4. Opaleye Management Inc. 10% owner
    Sale
    $2.1M 1,082,459 shares at $1.94 9.4% of stake
    Traded Nov 12, 2025 Filed Nov 14, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 9 sales to cover taxes and 2 stock grants.

SEC filings

Recent issuer filings from EDGAR, 23 shown.

Filed Form Detail Links
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G — Filing Doc
8-K 8.01,9.01 Filing Doc
424B5 Filing Doc
8-K 2.02,8.01 Filing Doc
424B5 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 5.07 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G/A — Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
SCHEDULE 13G — Filing Doc
8-K 5.02 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G — Filing Doc
8-K 2.02,9.01 Filing Doc
10-K Filing Doc
SCHEDULE 13G/A — Filing Doc

Source: SEC EDGAR submissions, updated 2 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $70.14M $59.34M $70.39M
Gross profit * $57.33M $43.06M $61.05M
Gross margin * 81.7% 72.6% 86.7%
Net income -$76.24M -$65.28M -$43.97M
Net margin * -108.7% -110.0% -62.5%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $93.47M $98.77M $96.82M
Total non-current assets * $43.1M $50.24M $50.98M
Total assets $136.56M $149.01M $147.8M
Total current liabilities $35.83M $23.65M $25.32M
Total non-current liabilities * $14.12M $58.44M $71.95M
Total equity $86.62M $66.93M $50.53M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$52.64M -$49.41M -$19.38M
Cash from investing -$4.86M -$56.98M $23.5M
Cash from financing $8.17M $60.52M $27.93M
Net change in cash -$49.33M -$45.87M $32.05M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.